Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: PROTAC EZH2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in refractory small cell lung cancer with leptomeningeal metastasis

Fig. 1

A: Timeline of in vivo drug testing in this study. B: In vivo imaging of leptomeningeal metastases in mice. The colour scale indicates the photon flux (photon/s) emitted from each group. C: Quantitative bar graph representing the total photon flux calculated from the region of interest. The data are presented as the means ± SDs, “*” indicates P < 0.05. D: Following the euthanasia of the mice, LM tumour tissues were extracted and subjected to weight measurements. E: The mean tumour weight is depicted in the bar graphs; error bars represent standard deviation. “*” represents P < 0.05

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us